Cargando…

Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease

Alzheimer’s disease is a neurological disorder that results in cognitive and behavioral impairment. Conventional treatment strategies, such as acetylcholinesterase inhibitor drugs, often fail due to their poor solubility, lower bioavailability, and ineffective ability to cross the blood–brain barrie...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonseca-Santos, Bruno, Gremião, Maria Palmira Daflon, Chorilli, Marlus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531021/
https://www.ncbi.nlm.nih.gov/pubmed/26345528
http://dx.doi.org/10.2147/IJN.S87148

Ejemplares similares